Conrad D. Oja

Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer

Matti Annala, Gillian Vandekerkhove, Daniel Khalaf et al. · Cancer Discovery · 2018 · 507 citations · Full text

Pathology, Rapid Resistance, Invasive Biomarkers +17

Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial

Daniel Khalaf, Matti Annala, Sinja Taavitsainen et al. · The Lancet Oncology · 2019 · 338 citations

Urology, Oncology, Optimal Sequencing +8

Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer

Pamela J. Goodwin, Bingshu E. Chen, Karen A. Gelmon et al. · JAMA · 2022 · 207 citations · Full text

Effect of Metformin vs Placebo on and Metabolic Factors in NCIC CTG MA.32

Pamela J. Goodwin, Wendy R. Parulekar, Karen A. Gelmon et al. · JNCI Journal of the National Cancer Institute · 2015 · 129 citations · Full text

Influence of dose on liposome clearance: critical role of blood proteins

Conrad D. Oja, Sean C. Semple, Arcadio Chonn et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 1996 · 116 citations

Lipid Preparation, Thrombosis, Biochemistry +9